Changing the way we deliver therapeutics
Insights
Below you’ll find insights into DNA nanotechnology and the biotech space. We will feature lay-reviews of recent scientific papers in addition to our own opinions and thoughts on the field as a whole. We’ll add information on recent trends in Gene Therapy, Immunotherapy, Drug Delivery, Diagnostics, and Industry Insights. Including the intricacies of DNA Origami Nanostructures, shaping the next phase of biotechnology. Stay informed and enlightened as we unravel the boundless potential of precision medicine in modern healthcare.
AACR – 2024 – Gene Delivery Poster
AACR – 2024 – Drug Delivery Poster
Current State of Antibody Drug Conjugates: A Look into the Future with DNA Origami Nanobots
Current State of Antibody Drug Conjugates: A Look into the Future with DNA Origami Nanobots Antibody Drug Conjugates (ADCs) have emerged as a beacon of hope in the fight against cancer. These complex molecules ingeniously harness the targeting capabilities of...
MagicDNA 2.0 – Revolutionizing DNA Design
Revolutionizing DNA Design: A Peek into MagicDNA's Advanced Capabilities The fascinating world of DNA origami has reshaped our understanding of genetic material, revealing its potential as more than just a biological code. As this technique evolved, so did the tools...
The Current State of Gene Delivery: Promise and Limitations
The Current State of Gene Delivery: Promise and Limitations Gene delivery holds transformative potential for the treatment of human disease. As our understanding of genetics and molecular delivery has deepened, the promise of curing genetic diseases by repairing or...
Precision Medicine: The Pioneers and How DNA Nanobots Could Take It to the Next Level
Precision Medicine: The Pioneers and How DNA Origami Could Take It to the Next Level Precision medicine, an approach that tailors medical treatments to individual patient characteristics, has taken significant strides in recent years. Among the most prominent...
let’s get connected
Have a Question?
Reach Out Anytime.